A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain

Shaun Bhatia, Nicole Olczyk, Leonard A Jason, Jose Alegre, Judith Fuentes-Llanos, Jesus Castro-Marrero, Shaun Bhatia, Nicole Olczyk, Leonard A Jason, Jose Alegre, Judith Fuentes-Llanos, Jesus Castro-Marrero

Abstract

Cross-national comparative studies are useful for describing the unique characteristics of complex illnesses, and can reveal culture-specific traits of disease frequency/severity and healthcare. Though myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) are debilitating conditions found all over the world, few studies have examined their characteristics across different countries. The purpose of this study was to compare the levels of functional impairment and symptomatology in patients with ME and CFS at tertiary referral hospitals in the US and Spain. Four hundred twenty potentially eligible participants (N = 235 from the US and N = 185 from Spain) who met the 1994 Fukuda et al. definition for CFS were enrolled. Both samples completed the medical outcomes study 36-item short-form health survey (SF-36) as a proxy for impairment, and the DePaul Symptom Questionnaire (DSQ) for patient symptomatology. ANCOVA and, where appropriate, MANCOVA tests were used to compare the SF-36 and DSQ items for illness characteristics between the samples. The patients from Spain demonstrated significantly worse functioning than those from the US in the SF-36 domains of physical functioning, bodily pain, general health functioning, role emotional, and mental health functioning. The Spanish sample also was also more symptomatic across all the DSQ-items, most significantly in the pain and neuroendocrine domains. These findings may be due to differences between the US and Spain regarding disability policy, perception of ME and CFS, and access to specialist care.

Keywords: Chronic fatigue syndrome; Cross-cultural comparison; Functional impairment; Myalgic encephalomyelitis; Observational descriptive study; Symptomatology.

Conflict of interest statement

Competing Interests: The authors declare that they have no competing interests.

References

    1. Berchick ER, Hood E and Barnett JC, 2018. Current population reports. US Government Printing office, Washington, DC. Health Insurance Coverage in the United States. pp: 60–264.
    1. Brown AA and Jason LA, 2014. Validating a measme of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology. Fatigue: Biomedicine, Health & Behavior, 2(3): 132–152.Available at: 10.1080/21641846.2014.928014.
    1. Brurberg KG, Fønhus MS, Larun L, Flottorp S and Malterud K, 2014. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): A systematic review. BMJ Open, 4(2): e003973.Available at: 10.1136/bmjopen-2013-003973.
    1. Carruthers BM, Jain AK, Meirleir DKL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P and Powles AP, 2003. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Jornnal of Chronic Fatigue Syndrome, 11(1): 7–115.Available at: 10.1300/j092v11n01_02.
    1. Castro-Marrero J, Faro M, Aliste L, Sáez-Francàs N, Calvo N, Martínez-Martínez A, de Sevilla TF and Alegre J, 2017. Comorbidity in chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide population-based cohort study. Psychosomatics, 58(5): 533–543.Available at: 10.1016/j.psym.2017.04.010.
    1. Castro-Marrero J, Sáez-Francàs N, Santillo D and Alegre J, 2017. Treatment and management of chronic fatigue syndrome /myalgic encephalomyelitis: All roads lead to Rome. British Jornnal of Pharmacology, 174(5): 345–369.Available at: 10.1111/bph.13702.
    1. Costa-Font J, Hita JC, Alonso J, Salvador-Carulla L and McDaid D, 2008. New and old challenges in the reform of mental health systems in Spain. Eurohealth-London, 14(4): 14–17.
    1. Estévez-López F, Castro-Marrero J, Wang X, Bakken IJ, Ivanovs A, Nacul L, Sepúlveda N, Strand EB, Pheby D and Alegre J, 2018. Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe-the Euro-epiME study from the European network EUROMENE: A protocol for a systematic review. BMJ Open, 8(9): e020817.Available at: 10.1136/bmjopen-2017-020817.
    1. European Cooperation in Science and Technology, 2015. Memorandmn of understanding for the implementation of the cost action “European network on myalgic encephalomyelitis/chronic fatigue syndrome” (EUROMENE) CA15111 (COST 043/15). Available from .
    1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG and Komaroff A, 1994. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121(12): 953–959.Available at: 10.7326/0003-4819-121-12-1994121S0-00009.
    1. Gandek B Sinclair SJ, Kosinski M and Ware JE Jr, 2004. Psychometric evaluation of the sf-36 [r] health survey in medicare managed care. Health Care Financing Review, 25(4): 5–26.
    1. Global Burden of Disease, 2016. Healthcare access and quality collaborators, 2018 measming performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: A systematic analysis from the global burden of disease study 2016. Lancet, 391(10136): 2236–2271.
    1. Hardt J, Buchwald D, Wilks D, Sharpe M, Nix WA and Egle UT, 2001. Health-related quality of life in patients with chronic fatigue syndrome: An international study. Journal of Psychosomatic Research, 51(2): 431–434.Available at: 10.1016/s0022-3999(01)00220-3.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N and Conde JG, 2009. Research electronic data capture (redcap)—a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2): 377–381. Available at: 10.1016/j.jbi.2008.08.010.
    1. Institute of Medicine, 2015. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. Washington, DC: The National Academies Press.
    1. Jason L and Sunnquist M, 2018. The development of the depaul symptom questionnaire: Original, expanded, brief, and pediatric versions. Frontiers in Pediatrics, 6: 330–330.Available at: 10.3389/fped.2018.00330.
    1. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang C-F and Plioplys S, 1999. A community-based study of chronic fatigue syndrome. Archives of Internal Medicine, 159(18): 2129–2137.Available at: 10.3346/jkms.2005.20.4.529.
    1. Jason LA, So S, Brown AA, Sunnquist M and Evans M, 2015. Test—retest reliability of the depaul symptom questionnaire. Fatigue: Biomedicine, Health & Behavior, 3(1): 16–32.Available at: 10.1080/21641846.2014.978110.
    1. Johnston S, Brenu EW, Staines D and Marshall-Graclisnik S, 2013. The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: A meta-analysis. Clinical Epidemiology, 5: 105–110.Available at: 10.2147/clep.s39876.
    1. McHorney CA, Ware JE Jr and Raczek AE, 1993. The mos 36-item short-form health survey (sf-36): Ii. Psychometric and clinical tests of validity in measming physical and mental health constructs. Medical Care: 247–263.Available at: 10.1097/00005650-199303000-00006.
    1. Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP and Vernon SD, 2017. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Quality of Life Research, 26(4): 913–921.Available at: 10.1007/s11136-016-1406-3.
    1. Nacul L, Lacerda E, Pheby D, Campion P, Molokhia M, Fayyaz S, Leite J, Poland F, Howe A and Drachler M, 2011. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) in three regions of england: A repeated cross-sectional study in primary care. BMC Medicine, 9(1): 91–91.Available at: 10.1186/1741-7015-9-91.
    1. Nombela-Monterroso K, González-Chordá V and Roman P, 2018. Descriptive study of the specialized care of the Spanish health system. Public Health Magazine, 52: 1–10.Available at: 10.11606/S1518-8787.2018052000289.
    1. Porthé V, Vargas I, Ronda E, Malmusi D, Bosch L and Vázquez ML, 2018. Has the quality of health care for the immigrant population changed during the economic crisis in Catalonia (Spain)? Opinions of health professionals and immigrant users. Gaceta Sanitaria, 32(5): 425–432.
    1. Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, Boneva RS, Morrissey M and Devlin R, 2007. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Population Health Metrics, 5: 5.Available at: 10.1186/1478-7954-5-5.
    1. Sharpe M, 1991. A report—chronic fatigue syndrome: Guidelines for research. Journal of the Royal Society of Medicine, 84(2): 118–121.Available at: 10.1177/014107689108400224.
    1. Song S, Jason LA and Taylor RR, 1999. The relationship between ethnicity and fatigue in a community-based sample. Journal of Gender, Culture and Health, 4(4): 255–268.Available at: 10.1037/e413782005-350.
    1. Sunnquist M, Nicholson L, Jason L and Friedman K, 2017. Access to medical care for individuals with myalgic encephalomyelitis and chronic fatigue syndrome: A call for centers of excellence. Modern Clinical Medicine Research, 1(1): 28–35.
    1. Wilson A, Hickie I, Hadzi-Pavlovic D, Wakefield D, Parker G, Straus SE, Dale J, McCluskey D, Hinds G and Brickman A, 2001. What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Australian and New Zealand Journal of Psychiatry, 35(4): 520–527.Available at: 10.1046/j.1440-1614.2001.00888.x.
    1. Zdunek M, Jason LA, Evans M, Jantke R and Newton JL, 2015. A cross-cultural comparison of disability and symptomatology associated with CFS. International Journal of Psychology and Behavioral Sciences, 5(2): 98–107.Available at: 10.5923/j.ijpbs.20150502.07.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever